With social distancing guidelines and mandates mostly lifted, people have begun to head back to beaches, parks and restaurants in many parts of the U.S. But you may ask: What's so different now compared to the situation ...
Jun 4, 2020
0
4
In a study just published in the journal Nature, scientists at the Deutsches Krebsforschungszentrum Heidelberg and at the Institute for Stem Cell Technology and Experimental Medicine have uncovered that environmental stress ...
Feb 18, 2015
1
369
Our bodies contain Natural Killer (NK) cells - an army that stops cancers and viruses before they can make us sick. A researcher from the University of Central Florida's College of Medicine has created a nanoparticle that ...
Dec 14, 2016
0
286
A decades-old medical mystery has been solved by researchers at UC San Francisco and St. Jude Children's Research Hospital in Tennessee, who have discovered a pair of inherited genetic mutations underlying a familial blood ...
Jul 30, 2018
0
129
A new study published in Nature Genetics led by the Mead Group in the Radcliffe Department of Medicine has demonstrated a previously unknown effect of chronic inflammation on TP53-mutant hematopoietic stem cells.
Sep 8, 2023
0
253
Two proteins ensure that cells can take up iron when needed. If both control proteins are switched off in mice, the animals develop severe anemia, as expected. At the same time, surprisingly, a cell type of the innate immune ...
Oct 7, 2022
0
67
A groundbreaking new type of cancer immunotherapy developed at the Icahn School of Medicine at Mount Sinai trains the innate immune system to help it eliminate tumor cells through the use of nanobiologics, tiny materials ...
Oct 29, 2020
0
236
(Medical Xpress)—What if you could attack cancer cells at their source without hurting the surrounding healthy cells? A group of researchers from the University of Virginia, the University of Massachusetts, Cornell University, ...
Led by researchers at Baylor College of Medicine, a study published in the journal Cell Stem Cell reveals a new mechanism that contributes to adult bone maintenance and repair and opens the possibility of developing therapeutic ...
Dec 9, 2019
0
733
The U.S. Food and Drug Administration (FDA) has approved the first ever inhibitor drug specifically approved for treating patients with relapsed or refractory acute myeloid leukemia (AML) with a mutation in the Fms-like tyrosine ...
Nov 28, 2018
0
5
